FFCP PHASE1:Mm9::chr11:97437755..97437763,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=11|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr11:97437755..97437763,-|id=chr11:97437755..97437763,-|ontology_enrichment_celltype=CL:0000115!3.50e-08!1;CL:0000213!3.50e-08!1;CL:0002078!3.50e-08!1;CL:0002262!3.50e-08!1;CL:1000398!3.50e-08!1|ontology_enrichment_celltype_v019_2=|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0002113!1.91e-12!14;UBERON:0003918!1.91e-12!14;UBERON:0005095!1.91e-12!14;UBERON:0007687!1.91e-12!14;UBERON:0006554!6.93e-11!16;UBERON:0001008!3.04e-10!17;UBERON:0000489!2.80e-08!21;UBERON:0000353!3.50e-08!1;UBERON:0003497!3.50e-08!1;UBERON:0003909!3.50e-08!1;UBERON:0003835!3.50e-08!1;UBERON:0003513!3.50e-08!1;UBERON:0001281!3.50e-08!1;UBERON:0001280!3.50e-08!1;UBERON:0004647!3.50e-08!1|ontology_enrichment_uberon_v019_2=UBERON:0002113,1.25e-13,14;UBERON:0003918,1.25e-13,14;UBERON:0011143,1.25e-13,14;UBERON:0005095,1.25e-13,14;UBERON:0007687,1.25e-13,14;UBERON:0006554,6.81e-11,18;UBERON:0001008,2.18e-10,19;UBERON:0000489,1.61e-09,21|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.340173160604279,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.289864488701678,0,0,0,0,0,0.140444420131752,0,0,0,0,0,0,0,0,0,0,0.22836775943812,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.258703370739016,0,0,0,0,0,0,0.205782136407943,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0701358198903186,0.442655759869801,0.590440591918409,1.56998727841375,2.22114895059241,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.221464689648775,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.136694227721025,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr11:97437755..97437763,-}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=11 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr11:97437755..97437763,- | |||
|description=CAGE_peak_at_chr11:97437755..97437763,- | |||
|id=chr11:97437755..97437763,- | |||
|ontology_enrichment_celltype=CL:0000115!3.50e-08!1;CL:0000213!3.50e-08!1;CL:0002078!3.50e-08!1;CL:0002262!3.50e-08!1;CL:1000398!3.50e-08!1 | |||
|ontology_enrichment_celltype_v019_2= | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0002113!1.91e-12!14;UBERON:0003918!1.91e-12!14;UBERON:0005095!1.91e-12!14;UBERON:0007687!1.91e-12!14;UBERON:0006554!6.93e-11!16;UBERON:0001008!3.04e-10!17;UBERON:0000489!2.80e-08!21;UBERON:0000353!3.50e-08!1;UBERON:0003497!3.50e-08!1;UBERON:0003909!3.50e-08!1;UBERON:0003835!3.50e-08!1;UBERON:0003513!3.50e-08!1;UBERON:0001281!3.50e-08!1;UBERON:0001280!3.50e-08!1;UBERON:0004647!3.50e-08!1 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0002113,1.25e-13,14;UBERON:0003918,1.25e-13,14;UBERON:0011143,1.25e-13,14;UBERON:0005095,1.25e-13,14;UBERON:0007687,1.25e-13,14;UBERON:0006554,6.81e-11,18;UBERON:0001008,2.18e-10,19;UBERON:0000489,1.61e-09,21 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.340173160604279,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.289864488701678,0,0,0,0,0,0.140444420131752,0,0,0,0,0,0,0,0,0,0,0.22836775943812,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.258703370739016,0,0,0,0,0,0,0.205782136407943,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0701358198903186,0.442655759869801,0.590440591918409,1.56998727841375,2.22114895059241,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.221464689648775,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.136694227721025,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr11:97437755..97437763,- | |||
}} |
Latest revision as of 11:36, 4 August 2015
Short description: | p@chr11:97437755..97437763, - |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr11:97437755..97437763, - |
Coexpression cluster: | MCL_coexpression_mm9:11 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
kidney | 1.25e-13 | 14 |
kidney mesenchyme | 1.25e-13 | 14 |
upper urinary tract | 1.25e-13 | 14 |
kidney rudiment | 1.25e-13 | 14 |
kidney field | 1.25e-13 | 14 |
urinary system structure | 6.81e-11 | 18 |
renal system | 2.18e-10 | 19 |
cavitated compound organ | 1.61e-09 | 21 |